50
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The burden of Plasmodium vivax infections has been underappreciated, especially in southeast Asia where chloroquine resistant strains have emerged. Our aim was to compare the safety and efficacy of dihydroartemisinin-piperaquine with that of artemether-lumefantrine in patients with uncomplicated malaria caused by multidrug-resistant P falciparum and P vivax.

          Related collections

          Author and article information

          Journal
          Lancet
          Lancet (London, England)
          Elsevier BV
          1474-547X
          0140-6736
          Mar 03 2007
          : 369
          : 9563
          Affiliations
          [1 ] International Health Programme, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.
          [2 ] National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia.
          [3 ] MSHR-NIHRD Malaria Research Programme, Timika, Indonesia; District Ministry of Health, Timika, Papua, Indonesia.
          [4 ] Public Health and Malaria Control Department, PT Freeport, Indonesia, Tembagapura, Papua, Indonesia; International SOS, Tembagapura, Papua, Indonesia.
          [5 ] Public Health and Malaria Control Department, PT Freeport, Indonesia, Tembagapura, Papua, Indonesia.
          [6 ] Directorate General of Centre for Disease Control and Environmental Health, Ministry of Health, Jakarta, Indonesia.
          [7 ] International Health Programme, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia; Centre for Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK. Electronic address: rnp@menzies.edu.au.
          Article
          S0140-6736(07)60160-3 UKMS1210
          10.1016/S0140-6736(07)60160-3
          2532500
          17336652
          4534aa98-c2a2-4fde-86a1-5f1eb796b84b
          History

          Comments

          Comment on this article